Year archive

LTR PHARMA LIMITED — 2026 filings

All 15 regulatory filings released by LTR PHARMA LIMITED (LTP) in 2026, sourced directly from the official regulator.

15 Filings

2026 Period

2026 filings (15)

Filing	Released	Lang
SPONTAN Phase II data show rapid onset, support FDA pathway 6 pages 280.1KB Legal Proceedings Report	2026-04-30	English
Investor Presentation 24 pages 2.6MB Investor Presentation	2026-04-30	English
Trading Halt 3 pages 220.7KB Regulatory Filings	2026-04-28	English
Quarterly Activities/Appendix 4C Cash Flow Report 10 pages 392.1KB Interim / Quarterly Report Q3 2026	2026-04-27	English
Investor Presentation 22 pages 2.4MB Investor Presentation	2026-03-10	English
SPONTAN Phase II Clinical Study Completes Recruitment 2 pages 152.1KB Legal Proceedings Report	2026-03-04	English
Appendix 4D and Half Yearly Report 38 pages 12.4MB Interim / Quarterly Report H1 2026	2026-02-25	English
Application for quotation of securities - LTP 6 pages 18.5KB Share Issue/Capital Change	2026-02-09	English
SPONTAN Shows Positive Outcomes in Younger Men with ED 3 pages 470.3KB Regulatory Filings	2026-02-01	English
Quarterly Activities/Appendix 4C Cash Flow Report 9 pages 380.8KB Interim / Quarterly Report Q4 2025	2026-01-27	English
First Patients Dosed in SPONTAN Phase II Clinical Study 2 pages 140.7KB Legal Proceedings Report	2026-01-21	English
Application for quotation of securities - LTP 6 pages 18.5KB Share Issue/Capital Change	2026-01-20	English
Notification regarding unquoted securities - LTP 6 pages 20.4KB Share Issue/Capital Change	2026-01-15	English
Patient Recruitment Commences for SPONTAN Phase II Study 2 pages 120.3KB Regulatory Filings	2026-01-12	English
SPONTAN Phase 1 Study Accepted for WMSM 2026 Podium 2 pages 465.5KB Regulatory Filings	2026-01-07	English